Nutrition & Care
Q3 2021
Sales in the Nutrition & Care segment rose considerably compared with the third quarter of 2020. This was due to considerable sales growth in the Care Chemicals division. Sales in the Nutrition & Health division matched the level of the prior-year quarter.
|
Nutrition & Care |
Care Chemicals |
Nutrition & Health |
---|---|---|---|
Volumes |
7% |
10% |
2% |
Prices |
7% |
10% |
0% |
Portfolio |
–2% |
–2% |
–2% |
Currencies |
0% |
0% |
0% |
Sales |
12% |
18% |
0% |
The sales performance was mainly attributable to higher volumes in both divisions. Sales volumes in the Care Chemicals division increased especially in the personal care solutions business and in the home care, industrial and institutional cleaning and industrial formulators business. Volumes in the Nutrition & Health division grew primarily in the pharmaceutical business.
Overall higher price levels contributed to sales growth. Prices rose in the Care Chemicals division, particularly in the oleo surfactants and fatty alcohols business, as well as in the home care, industrial and institutional cleaning and industrial formulators business. Prices in the Nutrition & Health division matched the level of the prior-year quarter.
Portfolio effects from the sale of the production site in Kankakee, Illinois, had a negative impact on sales.
The segment’s income from operations (EBIT) before special items was considerably below the level of the prior-year quarter. This was largely due to the significantly lower EBIT before special items in the Nutrition & Health division resulting primarily from lower margins associated with higher raw material and energy prices, which could only be passed on partially. EBIT before special items in the Care Chemicals division decreased slightly due mainly to higher fixed costs.
The decline in special items in the third quarter of 2021 was due primarily to the special charges for impairments and provisions in the prior-year quarter.
|
Q3 |
January–September |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
2021 |
2020 |
+/– |
2021 |
2020 |
+/– |
||||
Sales to third parties |
1,598 |
1,427 |
12% |
4,715 |
4,564 |
3% |
||||
of which Care Chemicals |
1,108 |
938 |
18% |
3,250 |
3,033 |
7% |
||||
Nutrition & Health |
490 |
489 |
0% |
1,465 |
1,531 |
–4% |
||||
Income from operations before depreciation, amortization and special items |
206 |
247 |
–17% |
761 |
966 |
–21% |
||||
Income from operations before depreciation and amortization (EBITDA) |
207 |
230 |
–10% |
815 |
941 |
–13% |
||||
Depreciation and amortizationa |
102 |
144 |
–29% |
301 |
356 |
–15% |
||||
Income from operations (EBIT) |
105 |
86 |
22% |
514 |
585 |
–12% |
||||
Special items |
1 |
–57 |
. |
54 |
–68 |
. |
||||
EBIT before special items |
104 |
143 |
–27% |
460 |
653 |
–30% |
||||
Assets (September 30) |
6,911 |
6,423 |
8% |
6,911 |
6,423 |
8% |
||||
Investments including acquisitionsb |
196 |
130 |
51% |
414 |
336 |
23% |
||||
Research and development expenses |
39 |
41 |
–5% |
122 |
115 |
6% |
||||
|